1. Patients launch $1.27 million crowdfunding campaign for ME/CFS gut microbiome study.
    Check out the website, Facebook and Twitter. Join in donate and spread the word!
9th Invest in ME International ME Conference, 2014 - Part 2: Pathogens and the Gut
Mark Berry continues his series of articles on the 9th Invest in ME International ME Conference in London, with the emphasis shifting from autoimmunity to pathogens and the gut ...
Discuss the article on the Forums.

Article: Treatment Breakthrough (and Paradigm Shift) For CFS? Rituximab Trial Promises Hope

Discussion in 'Phoenix Rising Articles' started by Phoenix Rising Team, Oct 28, 2011.

  1. Kelly

    Kelly

    Messages:
    85
    Likes:
    17
    I wonder what Dr. Chia thinks. He uses the herb oxymatrine to treat subgroups of patients, but warns that if the patient has a family history of autoimmune disease that it might not be a good option. The herb has been known to trigger autoimmune reactions. This highlights the possibility that just because patients have core symptoms in common it doesn't necessarily mean that the same treatment will work for everyone.
     
    Cort likes this.
  2. Enid

    Enid Senior Member

    Messages:
    3,309
    Likes:
    841
    UK
    Well my family does not have a history of autoimmune disease. Some suspicion from prostrate cancer (it's cause - viral - passed to my generation may hold a key). This is the best breakthrough for ME ever, a complete health breakdown - why - and researchers are on the way;
     
  3. Cort

    Cort Phoenix Rising Founder

    Messages:
    7,025
    Likes:
    441
    Raleigh, NC
    That's a really interesting point....Could you start to determine what percentage of patients have an autoimmunity by looking at who doesn't do well with oxymatrine??? or other immune stimulants? The more I learn about autoimmunity the more complex it is though. There are different kinds of autoimmune disorders and things that work for one will wipe out people with others.

    I have heard of 2 people with CFS who tried Rituximab and had bad results.....On the other hand Dr. Bateman noted that she has also seen people with CFS get better while they were on chemotherapy.
     
  4. Cort

    Cort Phoenix Rising Founder

    Messages:
    7,025
    Likes:
    441
    Raleigh, NC
    I agree about the need to get the 'noise' down and Rituximab might just be the drug to do it - splitting ME/CFS into those who respond and those who do not. I also imagine, as you noted, that the rate of positives will go down as more heterogeneous studies are done. Maes said he has data indicating that about 30% of people with CFS have a ve strong auto-immune condition and the rest do not. I wouldn't be surprised if it ends somewhere around there...which would be a huge win.

    Unless they can find a way to get more long lasting results my guess is that Rituximab, given its expense, will be more important for what it points to than the drug itself. The finding that some sort of auto-immune reaction is present in a subset of CFS patients, if its validated, has the much the same potential as XMRV to redefine the illness. The fact that it was 60% (as opposed to the upper 90% as the WPI felt as some point) is in its own way encouraging - since its hard to imagine that any one factor will be determinative for all patient.s
     
  5. Kelly

    Kelly

    Messages:
    85
    Likes:
    17
    Drug companies unlikely to pursue trials for drugs with a "low" success rate

    An issue that is rarely addressed is whether drug companies are interested in exploring treatments that appear to only work on a small percentage of patients. I think Ampligen works for about 15 % of patients and lets say Rituximab works for 30% of patients. For big companies that's not enough. Obviously, as Ian Lipkin noted in his WPI talk, in terms of advocacy patients need to stick together rather than splintering apart. But, in terms of effective treatment scientists must subset. Figuring out why only subsets of patients respond to certain treatments will go a long way toward figuring out the various disease mechanisms at play. Plus, if you define subsets accurately then in one sense, the treatment rate goes up.
     
  6. Sing

    Sing Senior Member

    Messages:
    1,311
    Likes:
    430
    New England
    I'm not sure that is true--that drug companies won't work to market a drug without a high success rate. A lot of drugs they have marketed do not work well for everyone--anti-depressants, ED drugs--to name some of the big sellers. Also they refer to their own positive studies only, and omit the negative ones, which they are allowed to do, amazingly. When more objective outcomes are noted years later, it turns out these drugs didn't work nearly as well as touted.
     
  7. hoMEy

    hoMEy

    Messages:
    80
    Likes:
    8
    The Matrix
    similar to antibiotics, if you make a person very toxic then the appearance of improvement via less microbes etc can appear significant, however the very treatment itself will stop them crossing the finishing line and the affects of long term high toxicity, which is what will happen like with abx because folk think their improving, is potentially harmfull to their condition and could create extra symptons/illnesses. stuff like this is scary because it may eventually be foisted on people who don't wish to take this course but may be encouraged/pushed to do so due to trial "results". why don't they completely recover?
     
  8. Sing

    Sing Senior Member

    Messages:
    1,311
    Likes:
    430
    New England
    hoMEy, I agree that sometimes we are overdosed with antibiotics, as with other drugs and treatments. We are floundering in the wilderness, it could be said, waging our own experimental wars or venturing on exploratory expeditions. I am very grateful for this forum where we try to share information and help each other with this struggle. It is fun to be in this with "you guys". Well, we just have to keep going!
     

See more popular forum discussions.

Share This Page